Cubist Pharmaceuticals (CBST): Q1 EPS of $0.82 beats by $0.19. Revenue of $211M (+30% Y/Y)...

|By:, SA News Editor
Cubist Pharmaceuticals (CBST): Q1 EPS of $0.82 beats by $0.19. Revenue of $211M (+30% Y/Y) in-line. Shares +3.2% AH. (PR)